Floor SpeechUrgent2026-06-24

Text of Senate Amendment 6117

Rand Paul
Rand Paul
RKY · Senator
Share:
HealthcareTaxesEnvironmentDefenseSocial SecurityEthics

Context

On 2026-06-24, Senator Rand Paul (R-KY) delivered a floor speech titled "Text Of Senate Amendment 6117" in the Senate.

Full Text

Text of Senate Amendment 6117

Congressional Record, Volume 172 Issue 106 (Wednesday, June 24, 2026) [Congressional Record Volume 172, Number 106 (Wednesday, June 24, 2026)] [Senate] [Pages S3325-S3327] From the Congressional Record Online through the Government Publishing Office [ www.gpo.gov ] SA 6117. Mr. PAUL submitted an amendment intended to be proposed by him to the bill S. 4784, to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows: At the end of title X, add the following: Subtitle H--Royalty Transparency Act SEC. 1094. SHORT TITLE. This subtitle may be cited as the ``Royalty Transparency Act''. SEC. 1095. FINANCIAL DISCLOSURE REPORTS OF EXECUTIVE BRANCH EMPLOYEES. (a) Individuals Required to File.-- (1) In general.--Section 13103 of title 5, United States Code, is amended-- (A) in subsection (f)-- [[Page S3326]] (i) in paragraph (11), by striking ``; and'' and inserting a semicolon; (ii) in paragraph (12), by striking the period and inserting ``; and''; and (iii) by adding at the end the following: ``(13) any member of-- ``(A) the National Science Advisory Board for Biosecurity; ``(B) the Advisory Committee on Immunization Practices; ``(C) the Advisory Commission on Childhood Vaccines; ``(D) the National Vaccine Advisory Committee; ``(E) the Vaccines and Related Biological Products Advisory Committee; ``(F) the Defense Science Board; ``(G) the Board of Scientific Advisors of the National Cancer Institute; ``(H) the Homeland Security Science and Technology Advisory Committee; ``(I) the Medical Review Board Advisory Committee; ``(J) the President's Council of Advisors on Science and Technology; or ``(K) except as provided in subsection (k), any other advisory committee, as defined in section 1001, including a successor to a committee described in this paragraph, that the Government Accountability Office determines, in accordance with subsection (j)-- ``(i) makes recommendations relating to public health to an agency or the President; and ``(ii) has had any recommendation fully or partially implemented during the 10 years preceding the determination.''; and (B) by adding at the end the following: ``(j) Determination Regarding Advisory Committees.--Not later than 180 days after the date of enactment of the Royalty Transparency Act, and annually thereafter, the Government Accountability Office shall publish a list of each advisory committee that the Government Accountability Office determines-- ``(1) makes recommendations relating to public health to an agency or the President; and ``(2) has had any recommendation fully or partially implemented during the 10 years preceding the determination. ``(k) Exception for Certain Members of Peer Review Groups.--Subsection (f)(13)(K) shall not include a member of an advisory committee if-- ``(1) the advisory committee is a peer review group, as defined in section 52h.2(k) of title 42, Code of Federal Regulations, or any successor regulation, within the National Institutes of Health; ``(2) for the applicable annual certification period, the Director of the National Institutes of Health, or the designee of the Director, in accordance with section 1096 of the Royalty Transparency Act, certifies annually to the Comptroller General of the United States, in such form and manner as the Comptroller General may require, that the National Institutes of Health has applied, with respect to each such member, the requirements relating to recusal for any actual or apparent conflict of interest under section 52h.5 of title 42, Code of Federal Regulations, or any successor regulation, and maintains documentation sufficient for review under section 1096 of the Royalty Transparency Act; and ``(3) the member of the advisory committee is not a special Government employee, as defined in section 202 of title 18, United States Code.''. (2) Sunset.--Effective on the date that is 5 years after the date of enactment of this Act, section 13103 of title 5, United States Code, as amended by this subtitle, is amended-- (A) in subsection (f)(13), by striking subparagraph (K) and inserting the following: ``(K) a successor to a committee described in subparagraphs (A) through (J) of this paragraph.''; and (B) by striking subsections (j) and (k), as added by paragraph (1)(B). (b) Notification of Waiver.-- (1) Title 5.--Section 13103(i) of title 5, United States Code, is amended-- (A) by moving the matter preceding paragraph (1) two ems to the left; (B) by redesignating paragraphs (1) through (4) as subparagraphs (A) through (D), respectively; (C) in the matter preceding subparagraph (A), as so redesignated, by striking ``the supervising ethics office determines'' and inserting ``the supervising ethics office-- ``(1) determines''; (D) in subparagraph (D), as so redesignated, by striking the period at the end and inserting ``; and''; and (E) by adding at the end the following: ``(2) provides notification of such waiver to the Committees on Homeland Security and Governmental Affairs and Commerce, Science, and Transportation of the Senate and the Committees on Oversight and Government Reform and Energy and Commerce of the House of Representatives.''. (2) Title 18.--Section 208 of title 18, United States Code, is amended by adding at the end the following: ``(e) Any exemption-- ``(1) granted under paragraph (1) or (3) of subsection (b) shall be immediately reported to the Committees on Homeland Security and Governmental Affairs and Commerce, Science, and Transportation of the Senate and the Committees on Oversight and Government Reform and Energy and Commerce of the House of Representatives, including a detailed justification for granting the waiver; or ``(2) granted under subpart (C) of part 2640 of title 5, Code of Federal Regulations, or any successor regulation, shall be immediately reported to the Committees on Homeland Security and Governmental Affairs and Commerce, Science, and Transportation of the Senate and the Committees on Oversight and Government Reform and Energy and Commerce of the House of Representatives, including a detailed justification for granting the waiver.''. (c) Contents of Reports.--Section 13104(a)(1) of title 5, United States Code, is amended-- (1) in subparagraph (A), by inserting ``, subject to subparagraph (C)'' after ``employment by the United States Government''; and (2) by inserting after subparagraph (B) the following: ``(C) Royalties received by government employees and committee filers.--Notwithstanding section 12(c) of the Stevenson-Wydler Technology Innovation Act of 1980 (15 U.S.C. 3710a(c)) and section 209 of title 35, if the reporting individual is an officer or employee in the executive branch (including a special Government employee, as defined in section 202 of title 18), or an individual described in section 13103(f)(13), the original source and amount or value of any royalties received by the reporting individual, the spouse of the reporting individual, or a dependent child of the reporting individual during the reporting period described in subsection (d) or (e) of section 13103, as applicable, that were received as a result of an invention developed by the reporting individual in the course of employment of the reporting individual with the United States Government, including any royalty interest payment made under the Federal Technology Transfer Act of 1986 (Public Law 99- 502; 100 Stat. 1785), an amendment made by such Act, or any other applicable authority.''. (d) Review of Reports.--Section 13107(b) of title 5, United States Code, is amended-- (1) in paragraph (1)-- (A) in the first sentence, by inserting ``and shall, in the case of an agency or office and notwithstanding section 12 of the Stevenson-Wydler Technology Act of 1980 (15 U.S.C. 3710a) and section 209 of title 35, publish such report on the internet website of the agency or office, as the case may be'' after ``to any person requesting such inspection or copy''; and (B) in the second sentence-- (i) by inserting ``, notwithstanding section 12 of the Stevenson-Wydler Technology Act of 1980 (15 U.S.C. 3710a) and section 209 of title 35,'' after ``such report shall''; and (ii) by inserting ``and, in the case of an agency or office, published on the internet website of the agency or office, as the case may be,'' after ``made available for public inspection''; (2) by striking paragraph (2) and the flush text following paragraph (2); (3) by redesignating paragraph (3) as paragraph (2); and (4) by adding at the end the following: ``(3) Procedure for releasing reports to members of congress.--Notwithstanding any other provision of law, not later than 30 days after receiving a request from a Member of Congress, any agency or supervising ethics office in the executive branch shall furnish to the Member of Congress a copy of any report submitted under this subchapter, which shall be unredacted, except with respect to social security numbers, dates of birth, home addresses, rental property addresses, phone numbers, email addresses, financial account numbers, signatures, and the personally identifiable information of dependent children.''. (e) Confidential Reports and Other Additional Requirements.--Section 13109 of title 5, United States Code, is amended-- (1) by redesignating subsections (b) and (c) as subsections (f) and (g), respectively; and (2) by inserting after subsection (a) the following: ``(b) Royalties Received by Confidential Filers.-- Notwithstanding section 12(c) of the Stevenson-Wydler Technology Innovation Act of 1980 (15 U.S.C. 3710a(c)) and section 209 of title 35, the information required to be reported under this section shall include the original source and amount or value of any royalties received by the reporting individual, or the spouse or any d
View original source →